FDA Calls for More Restrictions on Fluoroquinolone Use

Kristin J. Kelley, Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH The risks for "disabling and potentially permanent" side effects associated with systemic fluoroquinolone antibacterials (e.g., ciprofloxacin, moxifloxacin)…

Continue Reading FDA Calls for More Restrictions on Fluoroquinolone Use